Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study
Objective: To explore the effects of exposure to subcutaneous (sc) interferon (IFN) beta-1a on efficacy in patients with relapsing–remitting multiple sclerosis (RRMS) enrolled in the PRISMS (Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) study. Meth...
Glavni autori: | , , , , , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
SAGE Publishing
2011-01-01
|
Serija: | Therapeutic Advances in Neurological Disorders |
Online pristup: | https://doi.org/10.1177/1756285610391693 |